BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3037461)

  • 1. Superoxide (O2-) assay monocyte adherence test for the detection of cell-mediated immunity in cancer patients.
    Yagawa K; Kaku M; Ichinose Y; Hayashi S; Nakanishi M; Nomura Y; Shigematsu N
    Oncology; 1987; 44(3):142-4. PubMed ID: 3037461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide assay-leukocyte adherence inhibition test and a soluble factor which stimulates the adherence of macrophages.
    Yagawa K; Kaku M; Manabe H; Yasumoto K; Mashiba H; Iribe H; Yamagata J; Takenaka K; Nomura Y
    Cancer Res; 1980 Dec; 40(12):4791-5. PubMed ID: 6254653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated micro-monocyte adherence inhibition assay: a new technique of leukocyte adherence inhibition to detect tumor immunity in patients with hepatoma.
    Kumagai N; Morizane T; Inagaki Y; Nakamura T; Tsuchimoto K; Watanabe T; Tsuchiya M
    Gan; 1984 Nov; 75(11):1017-24. PubMed ID: 6097491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
    Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
    Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
    Tanaka F; Sawada K; Yonemoto RH
    Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leucocyte adherence inhibition with cryopresfrved mononuclear cells and autologous tumor extract (author's transl)].
    Onji M; Yamashita Y; Minakami Y; Ohta Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jul; 77(7):1122. PubMed ID: 6997583
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automation of the leukocyte adherence inhibition assay. Counting live mononuclear cells with an automated light microscope system.
    Waldman SR; Yonemoto RH
    J Immunol Methods; 1980; 34(4):269-78. PubMed ID: 6993565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein.
    Gouda Z; Thomson DM
    Jpn J Cancer Res; 1988 Apr; 79(4):529-37. PubMed ID: 2454907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adherence inhibition microtest for the detection of cell-mediated immunity to tumor in gastric cancer patients.
    Koyama S; Sakita T; Fukutomi H; Kawakita I; Tamura N
    Oncology; 1981; 38(1):13-7. PubMed ID: 7003459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D; Kaufmann M; Drings P; Fedra G
    Oncology; 1978; 35(6):242-5. PubMed ID: 370704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.